Healthconn Corp (6665.TWO) Q4 2024 Earnings Report

Healthconn Corp reported a strong QQ4 2024 set of results characterized by a notable jump in revenue alongside margin expansion and positive free cash flow. Revenue for the quarter reached 656.17 million TWD, with gross profit of 131.45 million (gross margin ~20.03%) and operating income of 20.43 million (operating margin ~3.11%). EBITDA stood at 30.52 million, and net income was 19.02 million, translating to basic and diluted EPS of 0.42 TWD. The company generated operating cash flow of 46.71 million and free cash flow of 34.81 million, while capex totaled 11.90 million, supporting a net cash position of approximately -60.93 million in net terms (net cash). The balance sheet remains robust with ample liquidity: current ratio of 2.30 and quick ratio of 2.04, and a net cash position despite carrying short-term debt of about 210.62 million and long-term debt of ~95.41 million. Total assets stood at ~1.522 billion, and total stockholders’ equity at ~0.948 billion. Management commentary on the call is not available in the provided data, but the results reflect continued demand for Healthconn’s disease prevention and health management services, including its Smart Health 365 platform and enterprise health management offerings. Investors should monitor the pace of scalable deployments in corporate health programs, payer mix dynamics, and ongoing efficiency initiatives that could further lift margins.